Skye Bioscience, Inc. (SKYE) Stock Overview
Explore Skye Bioscience, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Skye Bioscience, Inc. (SKYE)
Key Financials
Key Financials
Market Cap
10.8M
P/E Ratio
-0.25
EPS (TTM)
$-1.27
ROE
-3.29%
SKYE Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Skye Bioscience, Inc. (NASDAQ: SKYE) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Skye Bioscience, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of SKYE on the NASDAQ shows an RSI of 19.78, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind Skye Bioscience, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.25 and a market capitalization of 10.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SKYE on the NASDAQ.